Association of platelet-to-lymphocyte ratio levels with the risk of cardiac adverse events in people with type 2 diabetes undergoing percutaneous coronary intervention …
Y Song, Z Lin, J He, K Cui, C Song, R Zhang… - Diabetes & Metabolic …, 2024 - Elsevier
Background The platelet-to-lymphocyte ratio (PLR), a promising inflammatory biomarker,
contributes to the development of atherosclerosis and type 2 diabetes (T2D). Therefore, this …
contributes to the development of atherosclerosis and type 2 diabetes (T2D). Therefore, this …
A nightmare of clopidogrel resistance in a resource-limited setting: case report of subacute stent thrombosis
P Pallangyo, SV Bhalia, M Komba, ZS Mkojera… - The Egyptian Heart …, 2023 - Springer
Background Stent thrombosis, a life-threatening complication of percutaneous coronary
intervention (PCI) continues to occur despite effective antiplatelet regimens and improved …
intervention (PCI) continues to occur despite effective antiplatelet regimens and improved …
Association of serum platelet-to-lymphocyte ratio levels with the risk of stent thrombosis and long-term prognosis in patients undergoing percutaneous coronary …
Y Song, Z Lin, J He, K Cui, C Song, R Zhang, B Shi… - medRxiv, 2023 - medrxiv.org
Background The platelet-to-lymphocyte ratio (PLR) is a promising inflammatory biomarker
contributing to the development of atherosclerosis and type 2 diabetes mellitus (T2DM) …
contributing to the development of atherosclerosis and type 2 diabetes mellitus (T2DM) …
Frequency, Risk Factors, and Outcome of Definite Stent Thrombosis: Single-Center Experience
M Masoud, F Shireen, MW Jan - Journal of Health and Rehabilitation …, 2023 - jhrlmc.com
Background: Definite stent thrombosis presents a significant challenge in the field of
interventional cardiology, necessitating an in-depth understanding of its incidence, risk …
interventional cardiology, necessitating an in-depth understanding of its incidence, risk …